• TP53 Shapes Calicheamicin ADC Response in Acute Leukemia

  2026-08-25

  A genome-wide CRISPR/Cas9 screen identifies TP53, ATM, and MDM2 as major regulators of calicheamicin sensitivity in acute leukemia models. The findings distinguish DNA damage response dependencies that can enhance antibody–drug conjugate activity from PARP inhibition, which showed no broad sensitizing effect in the tested panel.

• SAR131675: VEGFR-3 Inhibitor Workflow Guide

  2026-08-24

  Use SAR131675 to separate VEGFR-3-dependent lymphatic signaling from broader endothelial phenotypes in biochemical, cellular, and tumor-model workflows. Its strong selectivity and nanomolar functional activity support mechanism-focused experiments, while its insolubility and discontinued development require disciplined formulation and interpretation.

• HOBt for High-Fidelity Amide Bond Formation

  2026-08-24

  HOBt supports controlled amide bond formation when stereochemical fidelity and mild reaction conditions matter. This guide translates its use from peptide synthesis into medicinal-chemistry workflows, including the indazole-based glucagon receptor antagonist series reported by Lin and colleagues.

• MPC, Lactate, and Histone Lactylation in CRC

  2026-08-23

  The reference study identifies a metabolic–epigenetic–immune pathway in colorectal cancer in which reduced MPC1/MPC2 activity increases lactate, elevates histone lactylation in dendritic cells, and weakens CD8+ T-cell responses. Its findings position MPC as a potential regulator of tumor progression and anti-PD-1 efficacy, while also providing a framework for studying lactate-dependent immune regulation.

• Cisplatin Workflows for Platinum-Resistance Studies

  2026-08-22

  Cisplatin (CDDP) provides a mechanistic benchmark for linking DNA crosslinking with apoptosis, oxidative stress, and platinum resistance. This workflow-oriented guide shows how to move from cell viability and apoptosis assays to xenograft studies while testing the CLK2–BRCA1 repair axis described in ovarian cancer research.

• Senescence Signatures in Abdominal Aortic Aneurysm

  2026-08-22

  This study combines transcriptomic analysis, machine learning, single-cell RNA sequencing, and experimental validation to identify senescence-related biomarkers associated with abdominal aortic aneurysm. ETS1 and ITPR3 emerged as the most consistent candidates, providing a foundation for earlier molecular detection while highlighting the need for prospective and mechanistic validation.

• Annexin-V Maps Cardiomyocyte Death After Cardiac I/R

  2026-08-21

  The reference study established labeled recombinant human annexin-V as an in situ method for detecting early cardiomyocyte death after myocardial ischemia and reperfusion. By resolving the timing of phosphatidylserine exposure in living mice, it provided a practical readout for evaluating interventions intended to limit ischemia/reperfusion-associated cell loss.

• Sulfachloropyridazine Research Workflows

  2026-08-20

  Sulfachloropyridazine connects DHPS-focused enzyme inhibition assays with antimicrobial susceptibility testing and microbiome-aware infection research. This workflow shows how to improve solubility control, interpret combination effects, and translate cecal microbiota findings into stronger experimental designs.

• Tankyrase Inhibition and the Hippo Cascade in HCC

  2026-08-20

  The reference study shows that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and increasing the YAP inhibitors AMOTL1 and AMOTL2. Its main contribution is to connect tankyrase inhibition with Hippo-pathway regulation, providing a mechanistic basis for combining tankyrase inhibitors with MEK or AKT pathway inhibitors.

• RepSox in hiPSC Platelet Differentiation Design

  2026-08-19

  RepSox is a potent ALK5 inhibitor for dissecting how TGF-β signaling influences hiPSC reprogramming and megakaryocyte maturation. This article connects a 2026 platelet-production study with a mechanistic, checkpoint-based assay strategy while separating validated findings from testable RepSox hypotheses.

• Carrier-Platin Triggers a Rapid ROS Storm in Cancer

  2026-08-19

  The reference study introduces carrier-platin, a platinum-based nanotherapeutic that confines ultrasmall platinum nanoparticles within a poly(amino acid) carrier to catalyze rapid intracellular ROS accumulation. Its reported cancer-killing activity occurs independently of DNA damage and differs from both apoptosis and ferroptosis, suggesting a distinct strategy for addressing drug-resistant tumors.

• Actinomycin D in LUAD: From Transcription to Translation

  2026-08-18

  Actinomycin D can serve as more than a cytotoxic reagent: it is a mechanistic stress test for connecting transcriptional control, mRNA persistence, and metastatic plasticity in lung adenocarcinoma. This article translates findings from the IGF2BP3/MCM5/Notch axis into a practical, evidence-aware workflow for mRNA stability, apoptosis induction, and translational model design.

• SAR131675: VEGFR-3 Inhibitor Workflow Guide

  2026-08-18

  SAR131675 enables selective interrogation of VEGFR-3-driven lymphatic endothelial survival, migration, and vascular remodeling. This workflow guide translates its nanomolar biochemical and cellular activity into practical assay design while separating validated anti-lymphangiogenic use-cases from exploratory kidney-disease applications.

• Clodronate Liposomes for In Vivo Macrophage Depletion

  2026-08-17

  Clodronate Liposomes provide phagocytosis-mediated delivery of liposome-encapsulated clodronate for experimental in vivo macrophage depletion. K2721 supports route- and tissue-specific macrophage perturbation, but depletion should not be interpreted as equivalent to CCL7 blockade or macrophage-specific genetic ablation.

• Actinomycin D Workflows for RNA Stability

  2026-08-17

  Actinomycin D converts transcriptional inhibition into a practical tool for mRNA decay, apoptosis induction, and transcriptional stress studies. This guide also shows how ActD can complement the circCHSY1–miR-24-3p–HO1 findings in myocardial ischaemia/reperfusion research without confusing a broad transcriptional perturbation with a gene-specific mechanism.

7886 records 1/526 page Next 12345 下5页 Last page